(Q50433834)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26697977%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26697977%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26697977%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Heleia Roca Ho

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26697977%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Lidia Anguiano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26697977%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sergi Clotet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26697977%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Marta Rebull

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26697977%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Julio Pascual

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26697977%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Maria Jose Soler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26697977%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

23 December 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26697977%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Renal Physiology

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26697977%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26697977%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26697977%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

F534-46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26697977%20AND%20SRC:MED&resulttype=core&format=json

Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Angiotensin-converting enzyme 2 is an essential regulator of heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Liganded vitamin D receptor displays anti-hypertrophic activity in the murine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Aliskiren ameliorates renal inflammation and fibrosis induced by unilateral ureteral obstruction in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Vitamin D inhibition of TACE and prevention of renal osteodystrophy and cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

1,25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Albumin inhibits the insulin-mediated ACE2 increase in cultured podocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Renin-angiotensin system within the diabetic podocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Myocardial effects of VDR activators in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Generation and characterization of a novel kidney-specific manganese superoxide dismutase knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

A high-throughput fluorimetric assay for angiotensin I-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

ACE2 alterations in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Daily exercise training protects against albuminuria and angiotensin converting enzyme 2 shedding in db/db diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Discrepancy between intrarenal messenger RNA and protein expression of ACE and ACE2 in human diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Vitamin d receptor activation mitigates the impact of uremia on endothelial function in the 5/6 nephrectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

ACE and ACE2 activity in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Renoprotective role of the vitamin D receptor in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00082.2015

10.1152/AJPRENAL.00082.2015

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26697977%20AND%20SRC:MED&resulttype=core&format=json

release_pdyioflzl5e2xcawyb4z4whxvu

3 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pdyioflzl5e2xcawyb4z4whxvu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference